Axonics® Announces Listing on the U.K.’s National Health Service Supply Chain for Its Sacral Neuromodulation System by mparnell | Nov 29, 2018 | Portfolio News
Aimmune Therapeutics Announces Closing of $98 Million Investment by Nestlé Health Science by mparnell | Nov 28, 2018 | Portfolio News
Rapid Micro Biosystems Announces New Vice President of Global Sales by mparnell | Nov 27, 2018 | Portfolio News
Encore Dermatology, Inc. Announces Phase 2 Safety Data Demonstrating Lower Systemic Drug Exposure With Impoyz™ (clobetasol propionate) Cream, 0.025% Compared to Temovate® (clobetasol propionate) Cream, 0.05% by mparnell | Nov 27, 2018 | Portfolio News
Inflazome Completes €40m ($46m) Series B Financing to Develop NLRP3 Inflammasome Inhibitors to Clinical Proof-of-Concept by mparnell | Nov 19, 2018 | Portfolio News